arrow
Back
D

Dong‐Wan Kim

seoul national university

72H-index
730Paper Count
3.3WCitation Count
Published Papers 115
Publication Date
In vitro evaluation of sacituzumab govitecan in non-small cell lung cancer with actionable genomic alterations
err2026-07-29
err0
errOAAI
errYerim Park; Soyeon Kim; Tae Min Kim; Miso Kim; Jeonghwan Youk; Dong-Wan Kim; Bhumsuk Keam
errShare
errSave
Repotrectinib in NTRK fusion–positive advanced solid tumors: a phase 1/2 trial
err2026-02-04
err0
errOAAI
errBenjamin Besse; Jessica J. Lin; Lyudmila Bazhenova; Koichi Goto; Adrianus Johannes de Langen; Dong-Wan Kim; Jürgen Wolf; Christoph Springfeld; Sanjay Popat; Darren W. T. Lim; Misako Nagasaka; Jung Yong Hong; Christina S. Baik; Alice Hervieu; Victor Moreno; Nong Yang; Kanthi Kollengode; Haisu Yang; Yuanfang Xu; Christophe Y. Calvet; Yong Yuan; Amy B. Hammell; Alexander Drilon; Benjamin J. Solomon
errShare
errSave
MAGELLAN arms B1 and B3: Durvalumab plus chemotherapy with and without oleclumab in treatment-naïve metastatic non-small-cell lung cancer
err2025-11-07
err0
PREAI
errByoung Chul Cho; Chaiyut Charoentum; Dong-Wan Kim; Cheng-Ta Yang; Rafal Dziadziuszko; Sarayut Lucien Geater; Helen Mann; Banafsheh Afshar-Imani; Pavlo Lyfar; James Chih-Hsin Yang; Sandip Pravin Patel
errShare
errSave
Phase II study of lazertinib and pemetrexed in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer and leptomeningeal metastases: The KCSG LU 21-01, LAZARUS study
err2025-11-01
err0
PREAI
errHyun-Ae Jung; Tae Min Kim; Hye Ryun Kim; Chang Gon Kim; Hee Kyung Ahn; Youngjoo Lee; Yu Jung Kim; Miso Kim; Jeonghwan Youk; Jong-Mu Sun; Se-Hoon Lee; Jin Seok Ahn; Dong-Wan Kim; Myung-Ju Ahn; Bhumsuk Keam
errShare
errSave
\zaAlectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: Final overall survival analysis of the Phase III ALEX study
err2025-10-17
err0
errOAAI
errS. Peters; R. Camidge; R. Dziadziuszko; S. Gadgeel; A.T. Shaw; D-W. Kim; M. Pérol; D.R. Rosell; P. Cheema; D.Wan-Teck Lim; J.J. Lin; N. Pavlakis; J.S. Ahn; L. Zhang; V. Henschel; A.A. Higgerson; V. McNally; I. Rooney; A. Scalori; V. Smoljanovic; T. Mok
errShare
errSave
errShare
errSave
The Synergistic Effect of PARP Inhibitors and Irinotecan in Small Cell Lung Cancer Cells
err2025-10-01
err0
errOAAI
errOh, Songji; Kim, Soyeon; Keam, Bhumsuk; Youk, Jeonghwan; Kim, Tae Min; Kim, Dong-Wan; Kim, Miso
errShare
errSave
Final analysis results and patient-reported outcomes from DESTINY-Lung02—a dose-blinded, randomized, phase 2 study of trastuzumab deruxtecan in patients with HER2-mutant metastatic non–small cell lung cancer
err2025-07-30
err0
PREAI
errPasi A. Jänne; Yasushi Goto; Toshio Kubo; Kiichiro Ninomiya; Sang-We Kim; David Planchard; Myung-Ju Ahn; Egbert Smit; Adrianus Johannes de Langen; Maurice Pérol; Elvire Pons-Tostivint; Silvia Novello; Hidetoshi Hayashi; Junichi Shimizu; Dong-Wan Kim; Kaline Pereira; Fu-Chih Cheng; Ayumi Taguchi; Yingkai Cheng; Kyle Dunton; Ahmed Ali; Koichi Goto
errShare
errSave
First-Line Lorlatinib Versus Crizotinib in Asian Patients With Advanced ALK-Positive NSCLC: Five-Year Outcomes From the CROWN Study
err2025-02-28
err0
errOAAI
errYi-Long Wu; Hye Ryun Kim; Ross A. Soo; Qing Zhou; Hiroaki Akamatsu; Gee-Chen Chang; Chao-Hua Chiu; Hidetoshi Hayashi; Sang-We Kim; Yasushi Goto; Terufumi Kato; Jianying Zhou; Victor Ho-Fun Lee; Makoto Nishio; Baohui Han; Dong-Wan Kim; Shun Lu; Anna Polli; Jean-François Martini; Francesca Toffalorio; Tony Mok
errShare
errSave
Genomic profiling of intimal sarcoma reveals molecular subtypes with distinct tumor microenvironments and therapeutic implications
err2025-01-01
err0
PREAI
errPark, C.; Kim, R.; Bae, J. M.; Lee, T.; Song, S.; Kwak, Y.; Lee, K. B.; Youk, J.; Keam, B.; Kim, T. M.; Kim, D. -w.; Kim, J. -i.; Choi, J.; Kim, M.
errShare
errSave
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib study
err2024-11-08
err0
errOAAI
errBazhenova, Lyudmila; Kim, Dong-Wan; Cho, Byoung Chul; Goel, Sanjay; Heist, Rebecca; Werner, Theresa L.; Eaton, Keith D.; Wang, Judy S.; Pant, Shubham; Adkins, Douglas R.; Blakely, Collin M.; Yan, Xiaohong; Neuteboom, Saskia; Christensen, James G.; Chao, Richard; Bauer, Todd
errShare
errSave
Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study
err2024-10-08
err0
errOAAI
errHan, Ji-Youn; Ahn, Myung-Ju; Lee, Ki Hyeong; Lee, Yun-Gyoo; Kim, Dong-Wan; Min, Young Joo; Kim, Sang-We; Cho, Eun Kyung; Kim, Joo-Hang; Lee, Gyeong-Won; Lee, Sung Sook; Lee, Na Mi; Jang, Hyun Woo; Han, Heewon; Park, Hyejoo; Lee, Jieon; Cho, Byoung Chul
errShare
errSave
Plain language summary: 5-year results from the CROWN study of lorlatinib vs crizotinib in non-small-cell lung cancer
err2024-10-03
err0
errOAAI
errSolomon, Benjamin J.; Liu, Geoffrey; Felip, Enriqueta; Mok, Tony S. K.; Soo, Ross A.; Mazieres, Julien; Shaw, Alice T.; de Marinis, Filippo; Goto, Yasushi; Wu, Yi-Long; Kim, Dong-Wan; Martini, Jean-Francois; Messina, Rossella; Paolini, Jolanda; Polli, Anna; Thomaidou, Despina; Toffalorio, Francesca; Bauer, Todd M.
errShare
errSave
Resistance mechanisms of EGFR tyrosine kinase inhibitors, in EGFR exon 20 insertion-mutant lung cancer
err2024-09-01
err1
PREAI
errPark, Siyeon; Park, Seongyeol; Kim, Tae Min; Kim, Soyeon; Koh, Jaemoon; Lim, Joonoh; Yi, Kijong; Yi, Boram; Ju, Young Seok; Kim, Miso; Keam, Bhumsuk; Kim, Jung Sun; Jeon, Yoon Kyung; Kim, Dong-Wan; Kim, Young Tae; Heo, Dae Seog
errShare
errSave
Transcriptomic Heterogeneity of EGFR-Mutant Non-Small Cell Lung Cancer Evolution Toward Small-Cell Lung Cancer
err2024-08-16
err0
PREAI
errOh, Songji; Koh, Jaemoon; Kim, Tae Min; Kim, Soyeon; Youk, Jeonghwan; Kim, Miso; Keam, Bhumsuk; Jeon, Yoon Kyung; Ku, Ja-Lok; Kim, Dong-Wan; Chung, Doo Hyun; Heo, Dae Seog
errShare
errSave
Synergistic effects of EZH1/2 dual inhibition and cisplatin on lung cancer cell lines with loss of SMARCA4 and SMARCA2
err2024-03-22
err0
PREAI
errLee, Jeongjae; Keam, Bhumsuk; Kim, Soyeon; Youk, Jeonghwan; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Seog, Heo Dae
errShare
errSave
Characterization of the phylogenetic relationships in bilateral breast angiosarcoma
err2024-03-22
err0
PREAI
errKim, Minju; Youk, Jeonghwan; Kim, Soyeon; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Song, Myung Geun; Koh, Jiwon; Bae, Jeong Mo; Moon, Hyeong-Gon; Im, Seock-Ah
errShare
errSave
Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial
err2024-02-13
err10
errOAAI
errBesse, Benjamin; Pons-Tostivint, Elvire; Park, Keunchil; Hartl, Sylvia; Forde, Patrick M.; Hochmair, Maximilian J.; Awad, Mark M.; Thomas, Michael; Goss, Glenwood; Wheatley-Price, Paul; Shepherd, Frances A.; Florescu, Marie; Cheema, Parneet; Chu, Quincy S. C.; Kim, Sang-We; Morgensztern, Daniel; Johnson, Melissa L.; Cousin, Sophie; Kim, Dong-Wan; Moskovitz, Mor T.; Vicente, David; Aronson, Boaz; Hobson, Rosalind; Ambrose, Helen J.; Khosla, Sajan; Reddy, Avinash; Russell, Deanna L.; Keddar, Mohamed Reda; Conway, James P.; Barrett, J. Carl; Dean, Emma; Kumar, Rakesh; Dressman, Marlene; Jewsbury, Philip J.; Iyer, Sonia; Barry, Simon T.; Cosaert, Jan; Heymach, John V.
errShare
errSave
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusions
err2024-02-13
err20
errOAAI
errKim, Dong-Wan; Schram, Alison M.; Hollebecque, Antoine; Nishino, Kazumi; Macarulla, Teresa; Rha, Sun Young; Duruisseaux, Michael; Liu, Stephen, V; Al Hallak, Mohammed Najeeb; Umemoto, Kumiko; Wesseler, Claas; Cleary, James M.; Springfeld, Christoph; Neuzillet, Cindy; Joe, Andrew; Jauhari, Shekeab; Ford, Jim; Goto, Koichi
errShare
errSave